New
Cagrilintide
Cagrilintide is a long-acting acylated amylin receptor agonist designed for metabolic research. Targets AMY1/2/3 receptors to study satiety signaling and energy homeostasis pathways.
Available SKUs
| Model | Specification | MOQ |
|---|---|---|
| CGL5 | 5mg / 10ml | 1 vial |
| CGL10 | 10mg / 10ml | 1 vial |
Product Overview
Cagrilintide is a long-acting acylated amylin receptor agonist designed for metabolic research. Targets AMY1/2/3 receptors to study satiety signaling and energy homeostasis pathways.
Research Applications
- Long-acting acylated amylin analog with extended research half-life
- Targets AMY1, AMY2, AMY3 and calcitonin receptors
- Modulates brainstem satiety signaling (area postrema)
- Synergistic potential with GLP-1 agonists in dual-pathway research
- C18 fatty diacid acylation for albumin binding
Key Features
- ≥99% purity confirmed by RP-HPLC and ESI-MS
- Certificate of Analysis provided
- For laboratory research use only
| Catalog Number | CGL |
|---|---|
| Target Receptors | AMY1, AMY2, AMY3, Calcitonin R |
| Modification | Amino acid substitutions + C18 fatty diacid acylation |
| Molecular Weight | ~3950 Da |
| Form | Lyophilized powder |
| Purity | ≥99% (RP-HPLC) |
| Storage | -20°C, desiccated |
| Reconstitution | Sterile water |
| Shelf Life | 24 months (unopened, proper storage) |
Related Products
New
Mazdutide
Mazdutide is a dual GLP-1/glucagon receptor agonist combining incretin and…
View Details →
New
Survodutide
Survodutide is a glucagon-biased dual GLP-1/glucagon receptor agonist optimized for…
View Details →
New
Cagrilintide + Semaglutide Blend (CagriSema)
CagriSema research blend: Cagrilintide (amylin) + Semaglutide (GLP-1) — dual-pathway…
View Details →Need OEM or a Custom Configuration?
We support practical, production-ready customization for peptides, sequences, and modifications. Share your synthesizer type, dimensions, modifications preference, and packaging needs—our team will confirm feasibility and lead time.